BioXcel Therapeutics, Inc. (BTAI) › Net IncomeBioXcel Therapeutics, Inc. (BTAI) — Net IncomeAnnual figures by fiscal year, from SEC filings.2017: -$4.54M2018: -$19.27M2019: -$32.97M2020: -$82.17M2021: -$106.93M2022: -$165.76M2023: -$179.05M2024: -$59.60M2025: -$69.90M-$69.90M2017Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$69.90M-17.3%2024-$59.60M+66.7%2023-$179.05M-8.0%2022-$165.76M-55.0%2021-$106.93M-30.1%2020-$82.17M-149.2%2019-$32.97M-71.1%2018-$19.27M-324.5%2017-$4.54M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share